Quantcast

Latest Neuroregeneration Stories

2014-07-15 23:05:17

Nerve repair company to announce results and host call for investors. Alachua, FL (PRWEB) July 15, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, will report results for the second quarter ended June 30, 2014 on Monday, August 4, 2014 after the close of the markets. The Company will host a conference call and webcast for the investment community on Monday, August 4, 2014 at 4:30 PM ET. Investors within the United...

2014-07-07 10:28:28

Neural Regeneration Research Researchers at the University of Birmingham, UK, led by Dr. Ben Scheven, Dr. Wendy Leadbeater and Ben Mead have discovered that stem cells isolated from the teeth, termed dental pulp stem cells (DPSC), can protect retinal ganglion cells (RGCs) from death following injury and promote regeneration of their axons along the optic nerve. RGC loss is the leading cause of blindness and can arise through traumatic injury or degenerative diseases such as glaucoma....

2014-06-18 23:11:38

Expanded outcomes data from the Ranger® Registry to be presented Alachua, FL (PRWEB) June 18, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, today announced the acceptance of two clinical presentations on the use of Avance® Nerve Graft and a scientific presentation on the use of coaptation aids in nerve repair at the 29th Congress of the Federation of European Societies for Surgery of the Hand (FESSH), June...

2014-06-09 23:07:46

Nerve Repair Company AXGN to participate in investor conference in New York Alachua, FL (PRWEB) June 09, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the $1.6 billion US peripheral nerve repair market, is scheduled to present at the 9th Annual JMP Securities Healthcare Conference on Tuesday, June 24, 2014 at 12:30pm (ET) at the Westin New York Grand Central. A live webcast and subsequent archived replay of the Company’s presentation may be accessed...

2014-06-04 23:10:04

$1.9 Million in Grant funding will explore application of novel stem cells and development of branched grafts for complex nerve repair Alachua, FL (PRWEB) June 04, 2014 AxoGen, Inc. (NASDAQ: AXGN), the emerging leader of the $1.6 billion U.S. peripheral nerve repair market, announced today that it would share in the award of two Department of Defense Grants totaling approximately $1.9 million with Brigham and Women’s Hospital in Boston (BWH). The grants, awarded to Principal...

2014-04-28 23:08:35

Company to feature portfolio of products for peripheral nerve repair, protection and regeneration at ACOMS Annual Meeting Alachua, FL (PRWEB) April 28, 2014 AxoGen, Inc. (NASDAQ: AXGN), the emerging leader of the $1.6 billion U.S. peripheral nerve repair market, announced today that it will be highlighting its products at the American College of Oral and Maxillofacial (ACOMS) 35th Annual Scientific Conference and Exhibition, April 27-30 in Las Vegas, Nevada. AxoGen is exhibiting its full...

2014-04-16 23:10:26

AxoGen, Inc. will report results for the first quarter ended March 31, 2014 on Wednesday, April 30, 2014 after the market closes. Alachua, Florida (PRWEB) April 16, 2014 AxoGen, Inc. (NASDAQ: AXGN), the emerging leader of the $1.6 billion U.S. peripheral nerve repair market, will report results for the first quarter ended March 31, 2014 on Wednesday, April 30, 2014 after the market closes. The Company will host a conference call and webcast for the investment community on Wednesday, April...

2014-04-15 08:31:21

OAKLAND, N.J., April 15, 2014 /PRNewswire/ -- Collagen Matrix, Inc. announced today that it has received FDA's 510(k) clearance of its Flexible Collagen Nerve Conduit for management of peripheral nerve injuries at nerve ends in the foot to reduce the formation of painful neuroma. This is the first and only nerve conduit to receive FDA clearance for treatment of neuroma formation at nerve ends. The product will be able to help patients suffering from pain as a result of conditions...

2014-04-11 08:24:20

DUBLIN, April. 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/kjxvb2/nerve_repair_and ) has announced the addition of the "Nerve Repair & Regeneration Market by Xenografts, Neuromodulation, External & Surgery - Global Trend & Forecast to 2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) This report categorizes the market into the peripheral nerve repair segment and the neuromodulation segment....

2014-04-01 14:58:41

A new discovery suggests it could one day be possible to chemically reprogram and repair damaged nerves after spinal cord injury or brain trauma. Researchers from Imperial College London and the Hertie Institute, University of Tuebingen have identified a possible mechanism for re-growing damaged nerve fibres in the central nervous system (CNS). This damage is currently irreparable, often leaving those who suffer spinal cord injury, stroke or brain trauma with serious impairments like loss...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related